Werbung
Werbung
KTTA
Pasithea Therapeutics Corp. Common Stock
0.93
USDGesponsert
+0.01
+0.98%
09. Jan., 15:57 UTC -5
Geschlossen
Nach-Markt
0.89
-0.04
-4.19%
KTTA Ergebnisberichte
Positives Überraschungsverhältnis
KTTA übertreffen die 1 der letzten 2Schätzungen.
50%
Nächster Bericht
Datum des nächsten Berichts
23. März 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.18
Implizierte Änderung von Q3 25 (Revenue/ EPS)
--
/--
Implizierte Änderung von Q4 24 (Revenue/ EPS)
--
/-92.53%
Pasithea Therapeutics Corp. Common Stock earnings per share and revenue
On 13. Nov. 2025, KTTA reported earnings of -- USD per share (EPS) for Q3 25, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q4 25, 3 analysts forecast an EPS of -0.18 USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
FAQ
What were Pasithea Therapeutics Corp. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Pasithea Therapeutics Corp. Common Stock reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to Pasithea Therapeutics Corp. Common Stock's Q3 2025 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Pasithea Therapeutics Corp. Common Stock expected to report next?
The next earning report is scheduled for 23. März 2026.
What are the forecasts for Pasithea Therapeutics Corp. Common Stock's next earnings report?
Based on 3
analysts, Pasithea Therapeutics Corp. Common Stock is expected to report EPS of -$0.18 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung